Global Longlife Hospital and Research Ltd

(543520)

Global Longlife Hospital and Research Limited is a multi-specialty tertiary care hospital based out of Gujarat, India. Originally incorporated in January of 2012, the Company was converted into a public limited company in August of 2021 and is currently lead by Promoter Mr. Suresh Jani and his family. The hospital has 110 beds and over 30 experienced consultants to provide quality healthcare services to its patients. Additionally, the Hospital utilizes technology to manage its clinical and administrative tasks, as well as for transmission of disease data and subsequent analysis.

The Hospital also has a dedicated team of healthcare staff members, consisting of Medical Directors, Quality Managers, Clinical Pharmacists, Microbiologists, Medical Officers, Clinical Assistants, Infection Control Nurses, Nursing Staff, Attendants, Paramedical Staff, Dieticians/Nutritionists, Medical Transcribers, and Biomedical Engineers, all of whom are well trained to take care of patients and handle emergencies. The services range across multiple specialties, including cardiology, allergy & immunology, oncology, diabetes & endocrinology, anesthesiology, and internal medicine, and have been awarded "The Best Emerging Hospital" by Times of India. The Company went public on May 04 2022, offering 3500000 equity shares of a face value of Rs. 10 each, raising a total of Rs. 49 crores.

Share Price: ₹36.30 per share as on 11 Oct, 2024 04:01 PM
Market Capitalisation: ₹34.65Cr as of today
Chairperson Name: Sureshkumar Babulal Jani